3.0.0 4672 2023-01-11T13:44:43Z 2023-01-11T13:44:43Z Senate S 2020-09-23 116 sshr00 Health, Education, Labor, and Pensions Committee Senate Standing Referred to 2020-09-23T22:29:21Z Stem Cell Therapeutic and Research Reauthorization Act of 2019 116 3520 HR 2019-06-27 Referred to the Subcommittee on Health. Related bill CRS TRANSPLANT Act of 2020 116 4764 HR 2020-12-14 Message on Senate action sent to the House. Related bill CRS 2020-09-23 sshr00 Health, Education, Labor, and Pensions Committee Senate Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S5835) IntroReferral 2020-09-23 Introduced in Senate IntroReferral 10000 9 Library of Congress R000122 Sen. Reed, Jack [D-RI] John Reed D RI F. N B001135 Sen. Burr, Richard [R-NC] Richard Burr R NC Mauze 2020-09-23 True S001203 Sen. Smith, Tina [D-MN] Tina Smith D MN 2020-09-23 True S001184 Sen. Scott, Tim [R-SC] Tim Scott R SC 2020-09-23 True Health Advisory bodies Blood and blood diseases Cell biology and embryology Congressional oversight Government studies and investigations Health programs administration and funding Medical research Organ and tissue donation and transplantation Research administration and funding Health 00 2020-09-23 Introduced in Senate 2020-11-04T16:09:25Z Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2020 or the TRANSPLANT Act of 2020

This bill modifies and reauthorizes through FY2025 the C.W. Bill Young Cell Transplantation Program, which provides support to patients who need a potentially life-saving bone marrow transplant or umbilical cord blood transplant. It also requires research and other activities related to stem cell therapies.

Specifically, the Department of Health and Human Services must conduct a periodic review of the science of using adult stem cells and birthing tissues in therapeutic treatments, and the National Institutes of Health must continue efforts to further the field of regenerative medicine using adult stem cells.

In addition, the Government Accountability Office must examine various issues related to the national blood stem cell workforce.

]]>

TRANSPLANT Act of 2020 Display Title TRANSPLANT Act of 2020 Short Title(s) as Introduced TRANSPLANT Act of 2020 Introduced in Senate IS Short Title(s) as Introduced Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2020 Introduced in Senate IS Official Title as Introduced A bill to reauthorize the Stem Cell Therapeutic and Research Act of 2005, and for other purposes. Introduced in Senate IS Introduced in Senate 2020-09-23T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-116s4672is/xml/BILLS-116s4672is.xml 2020-09-23 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S5835) text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.